GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
-
Published:2024-09
Issue:9
Volume:42
Page:1528-1548.e17
-
ISSN:1535-6108
-
Container-title:Cancer Cell
-
language:en
-
Short-container-title:Cancer Cell
Author:
Liu Ilon, Alencastro Veiga Cruzeiro Gustavo, Bjerke Lynn, Rogers Rebecca F., Grabovska Yura, Beck Alexander, Mackay Alan, Barron Tara, Hack Olivia A., Quezada Michael A., Molinari Valeria, Shaw McKenzie L., Perez-Somarriba Marta, Temelso Sara, Raynaud Florence, Ruddle Ruth, Panditharatna Eshini, Englinger Bernhard, Mire Hafsa M., Jiang Li, Nascimento Andrezza, LaBelle Jenna, Haase Rebecca, Rozowsky Jacob, Neyazi Sina, Baumgartner Alicia-Christina, Castellani Sophia, Hoffman Samantha E., Cameron Amy, Morrow Murry, Nguyen Quang-De, Pericoli Giulia, Madlener Sibylle, Mayr Lisa, Dorfer Christian, Geyeregger Rene, Rota Christopher, Ricken Gerda, Ligon Keith L., Alexandrescu Sanda, Cartaxo Rodrigo T., Lau Benison, Uphadhyaya Santhosh, Koschmann Carl, Braun Emelie, Danan-Gotthold Miri, Hu Lijuan, Siletti Kimberly, Sundström Erik, Hodge Rebecca, Lein Ed, Agnihotri Sameer, Eisenstat David D., Stapleton Simon, King Andrew, Bleil Cristina, Mastronuzzi Angela, Cole Kristina A., Waanders Angela J., Montero Carcaboso Angel, Schüller Ulrich, Hargrave Darren, Vinci Maria, Carceller Fernando, Haberler Christine, Slavc Irene, Linnarsson Sten, Gojo Johannes, Monje Michelle, Jones Chris, Filbin Mariella G.ORCID
|
|